Investor Presentation • Aug 12, 2025
Investor Presentation
Open in ViewerOpens in native device viewer
Hannover Re: The somewhat different reinsurer
June 2025

| 1 | Hannover Re Group | 2 |
|---|---|---|
| 2 | Property Casualty reinsurance Property & Casualty reinsurance |
32 32 |
| 3 | Life Health reinsurance Life & Health reinsurance |
42 42 |
| 4 | Investment management Investment management |
54 54 |
| 5 | Capital and risk management Capital and risk management |
59 59 |
| 6 | Interim results Q1/2025 Interim results Q1/2025 |
70 70 |
| 7 | Outlook Outlook |
78 78 |
| 8 | Appendix Appendix |
80 80 |

Hannover Re Group


1) Average for the years 2014 – 2024

Transition to IFRS 17: Insurance revenue vs. GWP down by an aggregate of 31.3%1)
| Non- IFRS 17 Rank |
17 | IFRS Rank |
Group | Country | Reinsurance Premiums (GWP) |
Reinsurance Revenue (gross) |
|---|---|---|---|---|---|---|
| 1 | Swiss Re | CH | 40,503 | |||
| 1 | Munich Re 3) | DE | 32,921 | |||
| 2 | Berkshire Hathaway Inc. | US | 27,453 | |||
| 2 | Hannover Re | DE | 26,995 | |||
| 3 | Lloyd's 4) | UK | 22,075 | |||
| 3 | SCOR | FR | 17,575 | |||
| 4 | RGA | US | 14,281 | |||
| 5 | Renaissance Re 5) | BM | 12,340 | |||
| 6 | Everest Re | BM | 11,460 | |||
| 7 | Arch Capital | BM | 9,113 | |||
| 8 | PartnerRe | BM | 9,102 | |||
| 4 | China Re | CN | 5,986 | |||
| 9 | MS&AD Insurance Group 6) | JP | 5,777 | |||
| 10 | 6) General Insurance Corp of India |
IN | 4,544 | |||
| 11 | MAPFRE RE | ES | 4,295 |
All figures in m. EUR; for further information please see AM Best "Market Segment Report" August 2024 (© AM Best Europe - Information Services Ltd. - used by permission)
1) To illustrate the contrast, AM Best used audited financial statements in 2022 and compared them to the restated 2022 figures under IFRS 17 for fourteen global IFRS reporting (re)insurers
2) All non-USD currencies converted to USD using foreign exchange rate at year-end 2023.
3) Results in prior years included global specialty insurance; the revenue associated with this line was removed from the reinsurance revenues for year-end 2023
4) Reflects total reinsurance premium written by all syndicates in the Lloyd's market. The above list includes insurance groups that write reinsurance business in the Lloyd's market. As such, reinsurance premium is included in both the insurance group's premium figure and the Lloyd's market's premium figure
5) Acquisition of Validus Re completed in October 2023. 2023 premiums for Validus were included on a pro-forma basis
6) Fiscal year ended March 31, 2024


About us


Focus

Grow

Accelerate
Profitability: Earnings growth: RoE EBIT growth
Economic value creation: Attractive dividends: Cost leadership: Capital strength: Credit ratings: Employee engagement: Environmental stewardship: CSM growth, xRoCA Ordinary dividend growth Cost/Reinsurance rev (gross) Solvency II ratio S&P, A.M. Best Engagement index CDP score
Sustainability and embedded governance
Increasing earnings will support continued dividend growth


3,900 Total staff of employees
Initial Public Offering of Hannover Re in 1994
Worldwide presence with subsidiaries and branches on all continents
Majority shareholder, 50.2% held by Talanx AG
Transacting all lines
of property & casualty and life & health reinsurance
12 Hannover Re: The somewhat different reinsurer

13 Hannover Re: The somewhat different reinsurer
Group structure supports our business model


Group Risk Management, Global Human Resources, Group Legal Services, Group Audit, Corporate Communications, Global Information Technology, Group Transformation and Operations, Group Strategic Development

Asset Management, Group Finance and Accounting, Reinsurance Valuation and Steering, Group Taxation, Coordination of International Operations, Investor and Rating Agency Relations

Coordination of P&C Business Group, Aviation & Marine, Credit, Surety and Political Risks, Quotations, North America, United Kingdom, Ireland & London Market

Catastrophe XL (Cat XL), Structured R/I (Advanced Solutions) and ILS, Retrocessions, Cyber & Digital

Facultative R/I, Asia-Pacific &
Sharon Ooi
Sub-Saharan Africa
Agricultural Risks, Continental Europe, Latin America and North Africa

Life & Health Services, Africa, Asia, Australia, Continental Europe, Latin America and Middle East

Longevity Solutions, North America, Bermuda, United Kingdom and Ireland



All figures in m. EUR unless otherwise stated


1) Cost (directly + non-directly attributable) / Reinsurance revenue (gross)
Revenue and EBIT per employee highlight competitive strength

Based on reported company data and f/x rates at 31.12.2024, own calculation. Peers: Everest Re, Munich Re, RGA, SCOR, Swiss Re

All figures in m. EUR
Change in shareholders' equity
All figures in m. EUR unless otherwise stated

RoE based on reported company data, own calculation. Peers: Everest Re, Munich Re, RGA, SCOR, Swiss Re 1) 2010 – 2022 IFRS4
No. 1 position on 5-year average RoE – significantly above peer average
| 2020 | 2021 | 2022 | 2023 | 1) | 20242) | 2020 – 2024 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | RoE | Rank | RoE | Rank | RoE | Rank | RoE | Rank | RoE | Rank | Avg. | Rank |
| Hannover Re | 8.2% | 1 | 10.8% | 2 | 14.1% | 1 | 19.0% | 3 | 21.2% | 1 | 13.8% | 1 |
| Peer | 5.5% | 2 | 13.9% | 1 | 6.4% | 3 | 23.3% | 1 | 10.1% | 4 | 10.4% | 2 |
| Peer | 4.0% | 3 | 9.7% | 4 | 13.2% | 2 | 16.2% | 5 | 18.2% | 2 | 9.9% | 3 |
| Peer | 3.2% | 5 | 4.5% | 6 | 5.1% | 4 | 11.2% | 6 | 7.2% | 5 | 8.8% | 4 |
| Peer | -3.1% | 6 | 5.7% | 5 | 2.6% | 5 | 22.3% | 2 | 15.0% | 3 | 7.2% | 5 |
| Peer | 3.7% | 4 | 7.3% | 3 | -5.2% | 6 | 18.0% | 4 | 0.1% | 6 | 6.1% | 6 |
| Average | 3.6% | 8.7% | 6.0% | 18.3% | 12.0% | 9.1% |
RoE based on company data, own calculation
All companies reported IFRS4/US-GAAP figures
1) Hannover Re, Munich Re, SCOR: IFRS 17 | RGA, Everest Re, Swiss Re: US-GAAP
2) Hannover Re, Munich Re, SCOR, Swiss Re: IFRS 17 | RGA, Everest Re: US-GAAP

2024: Increased ordinary and special dividend reflects positive earnings trend

Performance comparison (incl. reinvested dividends)

1) STOXX Europe 600 Insurance

1) Total shareholder return incl. reinvested dividends Source: Bloomberg, Frankfurt Stock Exchange


The action areas of our Environmental Strategy focus on environmental stewardship

1) CDP = Carbon Disclosure Project

1) base year 2019, applicable for Scope 1 and Scope 2 emissions of our liquid asset portfolio
| 1 | Hannover Re Group | 2 |
|---|---|---|
| 2 | Property Casualty reinsurance Property & Casualty reinsurance |
32 32 |
| 3 | Life Health reinsurance Life & Health reinsurance |
42 42 |
| 4 | Investment management Investment management |
54 54 |
| 5 | Capital and risk management Capital and risk management |
59 59 |
| 6 | Interim results Q1/2025 Interim results Q1/2025 |
70 70 |
| 7 | Outlook Outlook |
78 78 |
| 8 | Appendix Appendix |
80 80 |

Hannover Re Group
| 1 | 2 Property & Casualty reinsurance | 3 | 4 | 5 | 6 | 7 | 8 |

− Flexible cost base due to relatively higher share of business written via brokers (~2/3)



1) All lines of Property & Casualty reinsurance except those stated separately
| 1 | 2 Property & Casualty reinsurance | 3 | 4 | 5 | 6 | 7 | 8 |

Estimated premium income excluding Structured Reinsurance & ILS Numbers on the right as of 31.12.2024
35
| 1 | 2 Property & Casualty reinsurance | 3 | 4 | 5 | 6 | 7 | 8 |
Supported by the improved P&C reinsurance environment since 2023

All figures in m. EUR unless otherwise stated
Natural and man-made catastrophe losses 1)

37
| 1 | 2 Property & Casualty reinsurance | 3 | 4 | 5 | 6 | 7 | 8 |

All figures in m. EUR as at 31 December 2024 unless otherwise stated.
Figures unadjusted for changes in foreign exchange rate, i.e. based on actual exchange rates at respective year-end.
Resiliency reserves embedded in best estimate defined as the difference between net of reinsurance undiscounted booked reserves before tax and minority participations (based on
Hannover Re's own best estimates) and WTW's analysis. Up to 2022 the booked reserves are on an IFRS4 basis and from 2023 onwards these are on an undiscounted IFRS 17 LIC basis.
The WTW review is based on data provided by Hannover Re. See appendix for more detail.
− Growth supported by superior financial strength, favourable market positioning and long-standing customer relationships
Retrocession in line with plan: Reduced cession rate with expanded geographical protection
Successful expansion of strong portfolio in attractive pricing environment
| 1 | 2 Property & Casualty reinsurance | 3 | 4 | 5 | 6 | 7 | 8 |

0
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
18,000
2 Jan – 1 Apr 2025

Figures in EUR m. unless otherwise stated Underwriting year figures at unchanged f/x rates 1) Excluding specialty business mentioned separately
| 1 | Hannover Re Group | 2 |
|---|---|---|
| 2 | Property Casualty reinsurance Property & Casualty reinsurance |
32 32 |
| 3 | Life Health reinsurance Life & Health reinsurance |
42 42 |
| 4 | Investment management Investment management |
54 54 |
| 5 | Capital and risk management Capital and risk management |
59 59 |
| 6 | Interim results Q1/2025 Interim results Q1/2025 |
70 70 |
| 7 | Outlook Outlook |
78 78 |
| 8 | Appendix Appendix |
80 80 |

Hannover Re Group





All figures in m. EUR unless otherwise stated

CSM = Contractual Service Margin, LC = Loss Component
All figures in m. EUR unless otherwise stated

47 Hannover Re: The somewhat different reinsurer

Profitability depends largely on the underlying biometric risks
Profitability is less likely to be affected by the underlying biometric risks
Only in combination with risk solutions and/ or financial solutions
Mortality
Risk of paying more death benefits than expected
Longevity Risk of paying annuities longer than expected Risks

| Longevity: enhanced annuities1) Illustration: 50k single premium, male 65, 3% interest |
||||||||
|---|---|---|---|---|---|---|---|---|
| Status of health |
Healthy | Obesity | Diabetes | Cancer | ||||
| Annuity increase |
+0% (standard) |
+9% | +23% | +85% | ||||
| Monthly annuity |
244 | 267 | 300 | 452 |

1) Allows people in ill health to receive a higher regular income in recognition of the fact that they, on average, have a shorter life expectancy than a healthy person
49


50
Income protection/medical insurance Payment of claim incurred
Critical Illness Payment of lump sum insured

Coverage of > than 160 diseases Design, pricing & claims assessment Advice & training in underwriting risks Track record as innovator in the market
Products U/W systems Processes Biometrics Risk assessment
Innovative, e.g. products with little or no underwriting
Lean, e.g. distribution directly to individuals, without advisers
Cover of death, disease or disability risks at an appropriate cost
Support for proper medical & claims assessment
hr | Quirc, hr | ReFlex or hr | Ascent



Property & Casualty business Life & Health business





Partnership 03 Long term relationship

23 offices at the service of our clients
| 1 | Hannover Re Group | 2 |
|---|---|---|
| 2 | Property Casualty reinsurance Property & Casualty reinsurance |
32 32 |
| 3 | Life Health reinsurance Life & Health reinsurance |
42 42 |
| 4 | Investment management Investment management |
54 54 |
| 5 | Capital and risk management Capital and risk management |
59 59 |
| 6 | Interim results Q1/2025 Interim results Q1/2025 |
70 70 |
| 7 | Outlook Outlook |
78 78 |
| 8 | Appendix Appendix |
80 80 |

Hannover Re Group
| 1 | 2 | 3 | 4 Investment management | 5 | 6 | 7 | 8 |
Increase in ordinary investment income predominantly due to higher locked-in yields

All figures in m. EUR unless otherwise stated
| Moderate increase in 2024 in credits utilising selective market opportunities | ||||||
|---|---|---|---|---|---|---|
| Asset class | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Fixed Income | 87% | 85% | 86% | 83% | 85% | 86% |
| Governments | 42% | 42% | 40% | 42% | 41% | 38% |
| Semi-governments | 8% | 7 % |
8% | 8% | 9% | 10% |
| Corporates | 31% | 30% | 32% | 27% | 29% | 32% |
| Investment grade | 26% | 25% | 28% | 23% | 25% | 27% |
| Non-Investment grade | 4 % |
4 % |
4 % |
4 % |
4 % |
4 % |
| Covered Bonds | 4 % |
4 % |
4 % |
4 % |
4 % |
4 % |
| ABS/MBS/CDO | 2 % |
2 % |
2 % |
3% | 3% | 3% |
| Equities | 3% | 3% | 4% | 3% | 3% | 3% |
| Listed | <0.1% | 1% | 1% | 0% | 0% | 0% |
| Private Equities | 2 % |
3% | 3% | 3% | 3% | 3% |
| Real Assets (without Infra-Debt) | 5% | 5% | 5% | 7% | 7% | 7% |
| Others | 2% | 3% | 2% | 3% | 3% | 2% |
| Cash/STI | 3% | 3% | 3% | 3% | 2% | 2% |
| MV AuM in EUR bn.1 ) |
48.2 | 49.8 | 56.2 | 57.4 | 60.6 | 66.4 |
Economic view based on market values without outstanding commitments for Private Equity and Alternative Real Estate as well as fixed-income investments of EUR 1,909.0 m. (EUR 1,161.6 m.) as at 31 December 2024 1) 2019 – 2022 IAS 39 incl. Cash / >2023 IFRS9 excl. Cash
| 1 | 2 | 3 | 4 Investment management | 5 | 6 | 7 | 8 |
Duration-neutral strategy; modified duration changes rather result of yield curve deviations


Geographical allocation mainly in accordance with our broad business diversification
| Pfandbriefe, | Short-term | |||||
|---|---|---|---|---|---|---|
| Governments | Semi-governments | Corporates | Covered bonds, ABS | investments, cash | Total | |
| AAA | 24% | 53% | 1% | 66% | - | 24% |
| AA | 58% | 25% | 9% | 8% | - | 31% |
| A | 11% | 8% | 41% | 9% | - | 21% |
| BBB | 5% | 2% | 39% | 14% | - | 17% |
| <BBB | 3% | 12% | 10% | 3% | - | 7 % |
| Total | 100% | 100% | 100% | 100% | - | 100% |
| Germany | 18% | 23% | 9% | 16% | 8% | 15% |
| U K |
6% | 5% | 9% | 5% | 7 % |
7 % |
| France | 3% | 1% | 6% | 9% | 0% | 4% |
| GIIPS | 0% | 0% | 6% | 2% | 0% | 2% |
| Rest of Europe | 4% | 14% | 15% | 24% | 12% | 11% |
| USA | 48% | 16% | 29% | 21% | 26% | 33% |
| Australia | 5% | 8% | 8% | 9% | 5% | 7 % |
| Asia | 12% | 14% | 8% | 0% | 32% | 11% |
| Rest of World | 5% | 19% | 11% | 15% | 9% | 10% |
| Total | 100% | 100% | 100% | 100% | 100% | 100% |
| Total b/s values in m. EUR | 22,059 | 9,771 | 20,265 | 4,332 | 1,366 | 57,793 |
IFRS figures as at 31 December 2024
| 1 | Hannover Re Group | 2 |
|---|---|---|
| 2 | Property Casualty reinsurance Property & Casualty reinsurance |
32 32 |
| 3 | Life Health reinsurance Life & Health reinsurance |
42 42 |
| 4 | Investment management Investment management |
54 54 |
| 5 | Capital and risk management Capital and risk management |
59 59 |
| 6 | Interim results Q1/2025 Interim results Q1/2025 |
70 70 |
| 7 | Outlook Outlook |
78 78 |

Hannover Re Group
Use of hybrids, securitizations etc. Lowers cost of capital and levers RoE
| Nominal amount |
Issue date |
Issue ratings S&P/A.M. Best |
First call date |
Maturity | Coupon rate |
|---|---|---|---|---|---|
| EUR 750 m. | 2022-11-14 | A/- | 2033-02- 26 |
2043-08-26 | Until 2033-08-26: 5.88% p. a. and thereafter 3.75% p. a. above 3 months EURIBOR |
| EUR 750 m. | 2021-03-22 | A/- | 2031-12- 30 |
2042-06-30 | Until 2032-06-30: 1.38% p. a. and thereafter 2.33% p. a. above 3 months EURIBOR |
| EUR 500 m. | 2020-07-08 | A/- | 2030-07- 08 |
2040-10-08 | Until 2030-10-08: 1.75% p. a. and thereafter 3.00% p. a. above 3 months EURIBOR |
| EUR 750 m. | 2019-10-09 | A/- | 2029-07- 09 |
2039-10-09 | Until 2029-10-09: 1.12% p. a. and thereafter 2.38% p. a. above 3 months EURIBOR |

Competitive advantage through low cost of capital (WACC)
…protects balance sheet, reduces earnings volatility and lowers cost-of-capital

1) Plus expected premium As at January 2025

Hannover Re pioneered the first securitisation of natural catastrophe risks (Kover) followed by further transactions (K2-K6 & K-Cessions)
we started with the first-ever transfer of acquisition costs from L&H business to the capital market ( "L" deals, L1-L7)
| Group | S&P | AM Best |
|---|---|---|
| Berkshire Hathaway | AA+ | A++ |
| Munich Re | AA | A+ |
| Hannover Re | AA- | A+ |
| Swiss Re | AA- | A+ |
| XL Bermuda | 2) AA |
A+ |
| Lloyd's | AA- | A+ |
| Partner Re | 1) AA |
A+ |
| Everest Re | A+1) | A+ |
| SCOR | A+ | A |
As at 2nd June 2025
1) Negative Outlook
2) Positive Outlook

90% vs. some 50% for a Bermuda start-up
Stress tests for natural catastrophes after retrocessions
| Effect on forecast net income | 2023 | 2024 | ||
|---|---|---|---|---|
| in m. EUR | ||||
| Hurricane US | 100-year loss | -1,426 | -1,854 | |
| 250-year loss | -1,946 | -2,510 | ||
| Earthquake US West Coast | 100-year loss | -782 | -1,030 | |
| 250-year loss | -1,425 | -1,900 | ||
| Winter storm Europe | 100-year loss | -823 | -988 | |
| 250-year loss | -1,185 | -1,467 | ||
| Earthquake Japan | 100-year loss | -609 | -620 | |
| 250-year loss | -978 | -1,053 | ||
| Earthquake Chile | 100-year loss | -505 | -587 | |
| 250-year loss | -1,345 | -1,522 |
65 Hannover Re: The somewhat different reinsurer

1) Excluding minority shareholdings of EUR 636 m.
Eligible Own Funds Solvency Capital Requirements (SCR)
2) Hannover Re has implemented a minimum acceptable Solvency II ratio of 180% and a threshold of 200% All figures in m. EUR unless otherwise stated
Very good capitalisation supports further business growth.
Solvency ratio robust under stressed conditions
Sensitivities and stress tests
Solvency II ratio 31.12.2024

1) 250-year return period acc. to our internal model which is equivalent to an occurrence probability of 0.4% 2) Average stress level of +50 bps, differing by corporate bond issuer rating. Excl. government bonds and incl. impact of changes in dynamic volatility adjustment
67 Hannover Re: The somewhat different reinsurer
Solvency Capital Requirements
in m. EUR
11,080 8,051 21,032 6,920 2,618 6,083 405 711 5,657 3,029 Property & Casualty Life & Health Market Counterparty default Operational Required capital before tax Deferred taxes Required capital after tax Eligible own funds (2,604) (6,085) (5,244) (432) (654) (15,156) (7,033) (18,952) (2,741) 3%(3%) 34% (36%) diversification 44%(44%) 12%(14%) 42%(39%) 0%(0%) (9,636) (5,520) 16,736
As at 31 December 2024 (2023) Solvency capital requirements based on the internal model Capital allocation based on Tail Value-at-Risk taking account of the dependencies between risk categories
Reconciliation of IFRS Shareholders' equity vs. Solvency II own funds in m. EUR

As at 31 December 2024 1) Foreseeable dividends and distributions incl. non-controlling interests 2) Net deferred tax assets
69 Hannover Re: The somewhat different reinsurer
| 1 | Hannover Re Group | 2 |
|---|---|---|
| 2 | Property Casualty reinsurance Property & Casualty reinsurance |
32 32 |
| 3 | Life Health reinsurance Life & Health reinsurance |
42 42 |
| 4 | Investment management Investment management |
54 54 |
| 5 | Capital and risk management Capital and risk management |
59 59 |
| 6 | Interim results Q1/2025 Interim results Q1/2025 |
70 70 |
| 7 | Outlook Outlook |
78 78 |
| 8 | Appendix Appendix |
80 80 |

Hannover Re: The somewhat different reinsurer
Hannover Re Group

Figures in EUR unless otherwise stated
1) Subject to no major distortions in capital markets and/or major losses not exceeding the large loss budget of EUR 2.1 bn. in 2025
2) At unchanged f/x rates
71
3) Including foreseeable ordinary dividend recognized on a pro-rata basis


| Property & Casualty R/I | Q1/2024 | Q1/2025 | ∆-% |
|---|---|---|---|
| Reinsurance revenue (gross) | 4,743 | 5,087 | +7.2% |
| Reinsurance revenue (net) | 4,240 | 4,478 | +5.6% |
| Reinsurance service result | 509 | 272 | -46.6% |
| Reinsurance finance result | -228 | -283 | +23.9% |
| Investment income | 421 | 469 | +11.2% |
| Other result | -73 | -14 | -81.1% |
| Operating profit/loss (EBIT) | 629 | 444 | -29.4% |
| Combined ratio (net) | 88.0% | 93.9% | |
| New business CSM (net) | 1,453 | 1,538 | |
| New business LC (net) | -23 | -18 |
All figures in m. EUR unless otherwise stated
LC = loss component, NDIC = non-distinct investment component
− Further increase reflects continued high interest rates
− Strong ordinary income supported by higher fixed-income yields and very solid returns from alternative investments
− Currency result of 66 m (-7 m.)., mainly driven by weakening of USD
| Life & Health R/I | Q1/2024 | Q1/2025 | ∆-% |
|---|---|---|---|
| Reinsurance revenue (gross) | 1,929 | 1,883 | -2.4% |
| Reinsurance revenue (net) | 1,762 | 1,740 | -1.3% |
| Reinsurance service result | 211 | 243 | +15.3% |
| Reinsurance finance result | -33 | -51 | +52.7% |
| Investment income | 76 | 108 | +41.1% |
| Other result | -73 | -47 | -35.2% |
| Operating profit/loss (EBIT) | 181 | 253 | +39.7% |
| New business CSM (net) | 97 | 132 | |
| New business LC (net) | -8 | -8 | |
| NB CSM & LC incl. extensions on existing contracts |
176 | 215 |
− Decrease in revenue (f/x-adjusted -4.1%), mainly driven by US mortality
− Positive experience variance mainly driven by Mortality business, including one-off effect of 20 m.
− Strong ordinary result, prior year impacted derivative valuation
− Currency result improved to 1 m. (-30 m.)
All figures in m. EUR unless otherwise stated LC = Loss component
| in m. EUR | Q1/2024 | Q1/2025 | RoI |
|---|---|---|---|
| Ordinary investment income1 ) |
578 | 645 | 3.9% |
| Realised gains/losses | - 5 |
6 | 0.0% |
| Depreciations Real Assets, Impairments | -15 | -16 | -0.1% |
| Change in ECL | 3 | - 5 |
0.0% |
| FVTPL - valuation2) | -15 | - 5 |
0.0% |
| Investment expenses | -47 | -49 | -0.3% |
| Investment result | 498 | 577 | 3.5% |
| Investment result | 498 | 577 |
|---|---|---|
| Unrealised gains/losses on investments (OCI) | 31 Dec 24 | 31 Mar 25 |
| Fixed Income | -3,299 | -3,037 |
| Equities (non-recycling) | - 1 |
- 1 |
| Real Assets | 529 | 519 |
| Others (Participations etc.) | 355 | -52 |
| Total | -2,415 | -2,571 |
All figures in m. EUR unless otherwise stated
1) Incl. results from associated companies
2) Fair Value Through P/L of financial instruments
| Property & Casualty R/I | Life & Health R/I | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Stand alone in m. EUR |
Q1/2024 | Q1/2025 | D-% | Q1/2024 | Q1/2025 | D-% | Q1/2024 | Q1/2025 | D-% |
| Reinsurance revenue (gross) | 4,743 | 5,087 | 7.2% | 1,929 | 1,883 | -2.4% | 6,673 | 6,970 | 4.5% |
| Reinsurance service expenses | -3,825 | -4,869 | 27.3% | -1,699 | -1,627 | -4.2% | -5,524 | -6,495 | 17.6% |
| Reinsurance service result (gross) | 918 | 218 | -76.2% | 231 | 256 | 11.1% | 1,149 | 474 | -58.7% |
| Reinsurance result (ceded) | -409 | 53 | -113.1% | -20 | -13 | -34.1% | -429 | 41 | -109.5% |
| Reinsurance service result | 509 | 272 | -46.6% | 211 | 243 | 15.3% | 720 | 515 | -28.5% |
| Reinsurance finance result | -228 | -283 | 23.9% | -33 | -51 | 52.7% | -261 | -333 | 27.6% |
| Investment result | 421 | 469 | 11.2% | 7 6 |
108 | 41.1% | 498 | 577 | 15.8% |
| Currency result | -7 | 66 | - | -30 | 1 | -102.9% | -37 | 66 | -279.1% |
| Other result | -66 | -79 | 20.4% | -44 | -48 | 10.8% | -109 | -128 | 17.4% |
| Operating profit/loss (EBIT) | 629 | 444 | -29.4% | 181 | 253 | 39.7% | 811 | 696 | -14.1% |
| Net income before taxes | 785 | 671 | -14.5% | ||||||
| Taxes | -213 | -178 | -16.3% | ||||||
| Net income | 571 | 492 | -13.8% | ||||||
| Non-controlling interest | 13 | 12 | -11.0% | ||||||
| Group net income | 558 | 480 | -13.9% |

0
900
1800
2700
| 1 | 2 | 3 | 4 | 5 | 6 Interim results Q1/2025 | 7 | 8 |
| Catastrophe losses1) in m. EUR |
Date | Gross | Net |
|---|---|---|---|
| California Wildfires, US | 7 - 31 Jan | 1,306.3 | 631.4 |
| Flood, Australia | 1 - 3 Feb | 12.0 | 10.9 |
| Cyclone Alfred, Australia | 7 - 10 Mar | 17.3 | 17.3 |
| Storms, US | 14 - 19 Mar | 14.5 | 14.5 |
| Earthquake, Myanmar | 28 Mar | 25.0 | 25.0 |
| 5 Natural catastrophes |
1,375.1 | 699.1 | |
| 1 Aviation | 38.4 | 28.8 | |
| 2 Property | 36.8 | 36.8 | |
| 3 Man-made losses |
75.2 | 65.6 | |
| 8 Major losses |
1,450.3 | 764.7 |
1) Major losses in excess of EUR 10 m. gross Large loss budget 2025: EUR 2,100 m., thereof EUR 400 m. man-made and EUR 1,700 m. NatCat

| 1 | Hannover Re Group | 2 |
|---|---|---|
| 2 | Property Casualty reinsurance Property & Casualty reinsurance |
32 32 |
| 3 | Life Health reinsurance Life & Health reinsurance |
42 42 |
| 4 | Investment management Investment management |
54 54 |
| 5 | Capital and risk management Capital and risk management |
59 59 |
| 6 | Interim results Q1/2025 Interim results Q1/2025 |
70 70 |
| 7 | Outlook Outlook |
78 78 |
| 8 | Appendix Appendix |
80 80 |

Hannover Re Group

2) Incl. discount effect of 6-7%, partly mitigated by prudent reserving
3) Subject to no major distortions in capital markets and/or major losses in 2025 not exceeding the large loss budget of EUR 2.1 bn.
| 1 | Hannover Re Group | 2 |
|---|---|---|
| 2 | Property Casualty reinsurance Property & Casualty reinsurance |
32 32 |
| 3 | Life Health reinsurance Life & Health reinsurance |
42 42 |
| 4 | Investment management Investment management |
54 54 |
| 5 | Capital and risk management Capital and risk management |
59 59 |
| 6 | Interim results Q1/2025 Interim results Q1/2025 |
70 70 |
| 7 | Outlook Outlook |
78 78 |
| 8 | Appendix Appendix |
80 80 |

Hannover Re Group
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 Appendix |
3 July 2025 Roadshow Zurich
12 August 2025 Conference Call on Q2/2025 financial results
Commerzbank & ODDO BHF Corporate Conference 2025, Frankfurt
Barclays Global Financial Conference, New York
11 September 2025 Natixis 2025 FIG Conference, Paris

Director Tel: +49 511 5604 - 1500 [email protected]

Axel Bock Senior Investor Relations Manager Tel: +49 511 5604 - 1736 [email protected]

Investor Relations Manager Tel: +49 511 5604 - 1530 [email protected]
| International Securities Identification Number (ISIN) | DE 000 840 221 5 |
|---|---|
| Ticker symbols | |
| -Bloomberg | HNR1 |
| -Thomson Reuters | HNRGn |
| -ADR | HVRRY |
| Exchange listings | |
| -Germany | Xetra, Frankfurt, Munich, Stuttgart, Hamburg, Berlin, Düsseldorf, Hannover (official trading: Xetra, Frankfurt and Hannover) |
| -USA | American Depositary Receipts (Level 1 ADR programme; 6 ADR = 1 share) |
| Market segment | Prime Standard |
| Index inclusion | DAX |
| First listed | 30 November 1994 |
| Number of issued shares1) | 120,597,134 |
| Common shares1) | EUR 120,597,134 |
| Share class | No-par-value registered shares |
This presentation does not address the investment objectives or financial situation of any particular person or legal entity. Investors should seek independent professional advice and perform their own analysis regarding the appropriateness of investing in any of our securities.
While Hannover Re has endeavoured to include in this presentation information it believes to be reliable, complete and up-to-date, the company does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of such information.
Some of the statements in this presentation may be forward-looking statements or statements of future expectations based on currently available information. Such statements naturally are subject to risks and uncertainties. Factors such as the development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements.
This presentation serves information purposes only and does not constitute or form part of an offer or solicitation to acquire, subscribe to or dispose of, any of the securities of Hannover Re.
© Hannover Rück SE. All rights reserved. Rights of third parties that are used under a Creative Commons licence and are to be guaranteed accordingly remain unaffected and are not to be restricted in any way. Hannover Re is the registered service mark of Hannover Rück SE.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.